Kestra Advisory Services, LLC Crispr Therapeutics Ag Transaction History

Kestra Advisory Services, LLC

$19.6 Billion
Q1 2025

A detailed history of Kestra Advisory Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 16,440 shares of CRSP stock, worth $625,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,440

Previous 16,008 2.7%

Holding current value

$625,377

Previous $630,000 11.27%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$34.03 - $53.02 $14,700 - $22,904	432 Added 2.7%	16,440 $559,000
Q4 2024 Feb 10, 2025	BUY	$38.65 - $55.15 $148,531 - $211,941	3,843 Added 31.59%	16,008 $630,000
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $176,204 - $247,799	-3,949 Reduced 24.51%	12,165 $571,000
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $20,826 - $27,749	407 Added 2.59%	16,114 $870,000
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $261,487 - $384,107	4,310 Added 37.82%	15,707 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $222,798 - $416,406	5,769 Added 102.51%	11,397 $713,000
Q3 2023 Nov 09, 2023	SELL	$45.39 - $59.0 $21,287 - $27,671	-469 Reduced 7.69%	5,628 $255,000
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $3,999 - $6,234	92 Added 1.53%	6,097 $342,000
Q1 2023 May 12, 2023	SELL	$41.0 - $56.12 $11,316 - $15,489	-276 Reduced 4.39%	6,005 $271,000
Q4 2022 Jan 31, 2023	SELL	$39.19 - $65.67 $17,909 - $30,011	-457 Reduced 6.78%	6,281 $255,000
Q3 2022 Nov 01, 2022	SELL	$61.1 - $83.78 $6,048 - $8,294	-99 Reduced 1.45%	6,738 $440 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $61,689 - $105,355	1,427 Added 26.38%	6,837 $415,000
Q1 2022 Apr 26, 2022	BUY	$53.19 - $79.24 $58,615 - $87,322	1,102 Added 25.58%	5,410 $339,000
Q4 2021 Jan 20, 2022	SELL	$70.09 - $111.29 $572,214 - $908,571	-8,164 Reduced 65.46%	4,308 $326,000
Q3 2021 Oct 19, 2021	BUY	$110.2 - $156.64 $29,974 - $42,606	272 Added 2.23%	12,472 $1.4 Million
Q2 2021 Jul 28, 2021	BUY	$100.84 - $161.89 $627,123 - $1.01 Million	6,219 Added 103.98%	12,200 $1.98 Million
Q1 2021 May 10, 2021	SELL	$110.72 - $210.04 $526,584 - $998,950	-4,756 Reduced 44.3%	5,981 $728,000
Q4 2020 Jan 20, 2021	BUY	$79.67 - $173.23 $855,416 - $1.86 Million	10,737 New	10,737 $1.74 Billion

Others Institutions Holding CRSP

# of Institutions

479

Shares Held

64.2M

Call Options Held

2.15M

Put Options Held

1.92M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $2.97B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Crispr Therapeutics Ag Transaction History